Replies to post #375172 on Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

There is no indication Lannett is continuing their contract with Elite beyond March. That’s a done deal and companies are parting ways with Adderall distribution.

There still is Vigabatrin that has yet to launch. Bioequivalency trials were completed back in 2018 for this if I remember right offhand. Been a long time.